Cargando…

Risk Factors for Alzheimer’s Disease: Focus on Stress

In vulnerable individuals, chronic and persistent stress is an established risk factor for disorders that are comorbid with Alzheimer’s disease (AD), such as hypertension, obesity and metabolic syndrome, and psychiatric disorders. There are no disease-modifying drugs in the treatment of AD, and all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caruso, Alessandra, Nicoletti, Ferdinando, Gaetano, Alessandra, Scaccianoce, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746823/ https://www.ncbi.nlm.nih.gov/pubmed/31551781 http://dx.doi.org/10.3389/fphar.2019.00976

Ejemplares similares

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease
por: Novakovic, Dijana, et al.
Publicado: (2013)

Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities
por: Caruso, Alessandra, et al.
Publicado: (2022)

Amphetamine Modulation of Long-Term Object Recognition Memory in Rats: Influence of Stress
por: Colucci, Paola, et al.
Publicado: (2021)

Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
por: Steardo, Luca, et al.
Publicado: (2015)

Induction of the Wnt Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage
por: Matrisciano, Francesco, et al.
Publicado: (2011)

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
por: Piccialli, Ilaria, et al.
Publicado: (2022)

Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023)

Altered Waste Disposal System in Aging and Alzheimer’s Disease: Focus on Astrocytic Aquaporin-4
por: Valenza, Marta, et al.
Publicado: (2020)

Aberrant insulin signaling in Alzheimer's disease: current knowledge
por: Bedse, Gaurav, et al.
Publicado: (2015)

Editorial: Antioxidant and neuroprotective potential of alternative and complementary therapeutic approaches against Alzheimer’s disease
por: Singh, Sandeep Kumar, et al.
Publicado: (2023)

Microfluidic/HPLC combination to study carnosine protective activity on challenged human microglia: Focus on oxidative stress and energy metabolism
por: Privitera, Anna, et al.
Publicado: (2023)

Importance of Increasing Modifiable Risk Factors Knowledge on Alzheimer’s Disease Among Community Pharmacists and General Practitioners in Spain
por: Alacreu, Mónica, et al.
Publicado: (2019)

Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons
por: Orlando, Rosamaria, et al.
Publicado: (2022)

The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
por: Hassan, Syed Shams ul, et al.
Publicado: (2022)

Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy
por: Barbato, Gaetano, et al.
Publicado: (2022)

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
por: Caruso, Giuseppe, et al.
Publicado: (2021)

Antidepressant activity of fingolimod in mice
por: di Nuzzo, Luigi, et al.
Publicado: (2015)

Corrigendum: The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
por: Hassan, Syed Shams ul, et al.
Publicado: (2022)

The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
por: Valis, Martin, et al.
Publicado: (2019)

Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia Activation
por: Caraci, Filippo, et al.
Publicado: (2019)

Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
por: Scuderi, Caterina, et al.
Publicado: (2014)

Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2019)

Microglia Function in Alzheimer’s Disease
por: Solito, Egle, et al.
Publicado: (2012)

Cellular stress response, redox status, and vitagenes in glaucoma: a systemic oxidant disorder linked to Alzheimer’s disease
por: Trovato Salinaro, Angela, et al.
Publicado: (2014)

Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer’s disease based on interpretable machine learning
por: Lai, Yongxing, et al.
Publicado: (2022)

Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus
por: Mattei, Vincenzo, et al.
Publicado: (2017)

Trilateral association of autophagy, mTOR and Alzheimer’s disease: Potential pathway in the development for Alzheimer’s disease therapy
por: Subramanian, Arunkumar, et al.
Publicado: (2022)

Fluoxetine Prevents Aβ(1-42)-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1
por: Caraci, Filippo, et al.
Publicado: (2016)

Centella asiatica Alters Metabolic Pathways Associated With Alzheimer’s Disease in the 5xFAD Mouse Model of ß-Amyloid Accumulation
por: Speers, Alex B., et al.
Publicado: (2021)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
por: Streit, Wolfgang J., et al.
Publicado: (2012)

Nutraceuticals in cognitive impairment and Alzheimer’s disease
por: Mecocci, P., et al.
Publicado: (2014)

Modeling and Targeting Alzheimer’s Disease With Organoids
por: Papaspyropoulos, Angelos, et al.
Publicado: (2020)

Advances in Alzheimer’s disease’s pharmacological treatment
por: Conti Filho, Carlos Elias, et al.
Publicado: (2023)

Vesicular CLC chloride/proton exchangers in health and diseases
por: Picollo, Alessandra
Publicado: (2023)

Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease
por: Chen, Shi-Yu, et al.
Publicado: (2020)

Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
por: Cai, Jiangluyi, et al.
Publicado: (2021)

Therapeutic Effects of Natural Drugs on Alzheimer’s Disease
por: Ma, Yuan, et al.
Publicado: (2019)

Modeling Alzheimer’s disease: from past to future
por: Saraceno, Claudia, et al.
Publicado: (2013)

Verapamil and Alzheimer’s Disease: Past, Present, and Future
por: Popović, Natalija, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t8v6flqdvv7pe13la0a41619nu